Healthcare research technology firm Clario has expanded its collaboration with AliveCor to enhance the collection of medical-grade ECG data for clinical trials.
The partnership enables trial participants to use AliveCor's KardiaRx app and KardiaMobile 6L personal ECG solution to gather six-lead ECG readings from the comfort of their homes. This integration empowers pharmaceutical and biotech companies to explore decentralised and hybrid trial strategies, a departure from traditional on-site evaluations.
The KardiaRx app, integrated into Clario's clinical trial platform, streamlines the data collection process while safeguarding participant information. This advancement facilitates high-quality data acquisition, diverse participant recruitment, reduced site visits, and ultimately contributes to more successful clinical trials.
AliveCor's remote monitoring solutions align with the vision of comprehensive care for trial participants beyond medical facilities.
Recently, AliveCor also partnered with Luscii, offering the world's first 'virtual heart clinic in a box.’ This innovative solution aims to streamline the delivery of high-quality, remote patient monitoring to patients by hospitals and GPs.
Click here to read the original news story.